Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial
Arie Pieter Kappetein1*, MD, PhD; Patrick W. Serruys2, MD, PhD; Joseph F. Sabik3, MD; Martin B. Leon4, MD; David P. Taggart5, MD, PhD; Marie-Claude Morice6, MD; Bernard J. Gersh7, MD; Stuart J. Pocock8, PhD; David J. Cohen9, MD; Lars Wallentin10, MD, PhD; Ori Ben-Yehuda4, MD; Gerrit-Anne van Es11, PhD; Charles A. Simonton12, MD; Gregg W. Stone4, PhD
1. Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, The Netherlands; 2. International Centre for Circulatory Health, NHLI, Imperial College London, London, United Kingdom; 3. Department of Thoracic and Cardiovascular Surgery, The C
Aims: Coronary artery bypass graft (CABG) surgery is the standard of care for revascularisation of patients with left main coronary artery disease (LMCAD). Recent studies have suggested t
